Dr. Rachel Tate

How do you screen your SSc patients for ILD? HRCT is the optimal screening tool over PFTs and XR. Dr. Elizabeth Volkmann @RheumNow @RWCSmtg #rwcs2025

Remember to check the temporal, axillary, carotid, and subclavian arteries for possible halo sign with US in vasculitis. Additional data suggests getting US early (within 4 days of starting steroids) if possible, as halo sign declines after GC exposure. @anisha_dua @RheumNow @RWCSmtg #rwcs2025

“You can see extra-cranial vessel disease in LVV in up to 80% of patients.” @anisha_dua reminds us to get non-invasive imaging in all newly diagnosed LVV pts. #rwcs2025 @RheumNow @RWCSmtg

What does it take to achieve true precision medicine in rheumatology? We need genomic, transcriptomic, proteomic, metabolomic, and immune phenotypic archtyping. Dr. Tanaka @RWCSmtg #RWCS2025

A potential creative way to alleviate the rheumatology shortage. AI vs rheumatologist US evaluation similar. This is a first iteration but expect more info. @RWCSmtg @RheumNow #RWCS2025

Hey #rheumatology are you prescribing GLP-1s in your practice? @RWCSmtg @RheumNow

Heard of the “3 S” rule describing risk factors for developing ILD in RA pts? 1. Smoking 2. Seropositive 3. Sex (male) Remember these when evaluating your patients @RheumNow @RWCSmtg #RWCS2025

Mayo clinic long term study of pts dx with seronegative RA showed 15% changed dx (mostly SpA, seropositive RA,) nearly 30% were in drug free remission, and 15% were on b/tsDMARDs at 10 years. Similar results supported from other studies. Highlights consideration for re-evaluation of disease. @RheumNow @RWCSmtg #RWCS2025

I lost my crystal ball (confession, I’m not sure I ever had one) but determining which patients may progress to RA is very difficult/important. Drs @RheumNow and Kavanaugh @RWCSmtg reviewed potential predictive model from #EULAR2024 1. Hand/foot joint tenderness 2. AM stiffness > 30 mins 3. High titer RF or ACPA 4. + Doppler > 3 = 62% chance of progression Questions remain: timing of progression/response/speed of response, etc #RWCS2025

A wonderful blessing to start #rwcs 2025

Interesting! Study of pts w/ ANA(-) & dsDNA(+). 1 in 5 dx with APLS! Have others seen that? I have been disgregarding this pattern, though some of that is related to my in-house assay (seems overly-sensitive) & my bias against overdiagnosis #ACR24 @RheumNow Abstr#2391

The best part of #ACR2024 remains the people!

ACR fun with friends!

An amazing night in Chicago celebrating Dr. Bing Chang at the @ArthritisFdn Freedom of Movent gala. Dr. Chang was inspirational in my decision to join #rheumatology and it was such a fun treat to surprise him last night. Also great to see @CuoghiE. She remains a passionate and fearless warrior for our patients!

@LCalabreseDO @HealioRheum @RheumNow Absolutely! ❤️

‘ I’ve been off Twitter on a sabbatical from social media. This piece in @HealioRheum brought a little joy to me to share @RheumNow Rheumatologists get to see all the cool cases’: Hooked on Rheum with four fellows healio.com/news/rheumatol…

Why is it important to incorporate patient reported outcomes (PROs) into clinical trials? Because the intervention is for the patient, and we need to know what matters most to them. - Dr M Jolly @UnaMakris

Rct of > 200 patients with knee OA treated with usual care plus mtx vs pbo. Mtx titrated to 25mg weekly and showed improvement in pain score c/w PBO at 6 months w/o significant AEs! @Tuhina_Neogi @AM_Malf —will this change OA management?

What a team! What a conference! @AWIRGROUP

Drs. LianneGensler and Catherine Bakewell bring down the house @AWIRGROUP discussing pregnancy in rheum pts. One of my takeaways: Don’t use NSAIDs in these pts if you can avoid them. They may decrease implantation (some data in animals models) so discuss family planning with your patients! @KDAO2011 @vksandhumd @DrPujaMehta1 @MamutMary @UCSFRheum @RheumNow

@DrPujaMehta1 @MamutMary She’s amazing, like you!!!

We are so much fun! Check out those dropped jaws!